Author Title [ Type(Desc)] Year
Filters: Author is Ebrahimi, Marzieh  [Clear All Filters]
Journal Article
Abbaspanah B, Momeni M, Ebrahimi M, Mousavi SHadi. Advances in perinatal stem cells research: a precious cell source for clinical applications. Regen Med. 2018.
Fomeshi MRajabi, Ebrahimi M, Mowla SJavad, Firouzi J, Khosravani P. CD133 Is Not Suitable Marker for Isolating Melanoma Stem Cells from D10 Cell Line. Cell J. 2016;18(1):21-7.
Roudi R, Madjd Z, Ebrahimi M, Samani FSahraneshi, Samadikuchaksaraei A. CD44 and CD24 cannot act as cancer stem cell markers in human lung adenocarcinoma cell line A549. Cell Mol Biol Lett. 2013.
Dashti A, Ebrahimi M, Hadjati J, Memarnejadian A, Moazzeni SMohammad. Dendritic cell based immunotherapy using tumor stem cells mediate potent antitumor immune responses. Cancer Lett. 2016.
Ganji F, Abroun S, Baharvand H, Aghdami N, Ebrahimi M. Differentiation potential of o bombay human-induced pluripotent stem cells and human embryonic stem cells into fetal erythroid-like cells. Cell J. 2015;16(4):426-39.
Rahimi M, Sharifi-Zarchi A, Zarghami N, Geranpayeh L, Ebrahimi M, Alizadeh E. Down-Regulation of miR-200c and Up-Regulation of miR-30c Target both Stemness and Metastasis Genes in Breast Cancer. Cell J. 2020;21(4):467-478.
Fomeshi MRajabi, Ebrahimi M, Mowla SJavad, Khosravani P, Firouzi J, Khayatzadeh H. Evaluation of the expressions pattern of miR-10b, 21, 200c, 373 and 520c to find the correlation between epithelial-to-mesenchymal transition and melanoma stem cell potential in isolated cancer stem cells. Cell Mol Biol Lett. 2015;20(3):448-465.
Javadi A, Keighobadi F, Nekoukar V, Ebrahimi M. Finite-Set Model Predictive Control of Melanoma Cancer Treatment Using Signaling Pathway Inhibitor of Cancer Stem Cell. IEEE/ACM Trans Comput Biol Bioinform. 2019.
Sharifzad F, Ghavami S, Mardpour S, Mollapour M, Azizi Z, Taghikhani A, Łos MJ, Verdi J, Fakharian E, Ebrahimi M, et al. Glioblastoma cancer stem cell biology: Potential theranostic targets. Drug Resist Updat. 2019;42:35-45.
Shokraii F, Moharrami M, Motamed N, Shahhoseini M, Totonchi M, Ezzatizadeh V, Firouzi J, Khosravani P, Ebrahimi M. Histone Modification Marks Strongly Regulate CDH1 Promoter in Prostospheres as A Model of Prostate Cancer Stem Like Cells. Cell J. 2019;21(2):124-134.
Bakhshi M, Asadi J, Ebrahimi M, Moradi A-V, Hajimoradi M. Increased expression of miR-146a, miR-10b, and miR-21 in cancer stem-like gastro-spheres. J Cell Biochem. 2019.
Rahimi M, Sharifi-Zarchi A, Firouzi J, Azizmi M, Zarghami N, Alizadeh E, Ebrahimi M. An integrated analysis to predict micro-RNAs targeting both stemness and metastasis in breast cancer stem cells. J Cell Mol Med. 2019.
Azimi M, Totonchi M, Rahimi M, Firouzi J, Sahranavard P, Razavi AEmami, Memari F, Kamali F, Ebrahimi M. An Integrated Analysis to Predict micro-RNAs Targeting both Stemness and Metastasis in Human Gastric Cancer. J Gastroenterol Hepatol. 2020.
Ebrahimi M, Hassan ZMohammad, Mostafaie A, Mehrjardi NZare, Ghazanfari T. Purif ied Protein Fraction of Garlic Extract Modulates Cellular Immune Response against Breast Transplanted Tumors in BALB/c Mice Model. Cell J. 2013;15(1):65-75.
Norouzi M, Firouzi J, Sodeifi N, Ebrahimi M, Miller DW. Salinomycin-loaded Injectable Thermosensitive Hydrogels for Glioblastoma Therapy. Int J Pharm. 2021:120316.
Abdollahi P, Ebrahimi M, Motamed N, Samani FS. Silibinin affects tumor cell growth because of reduction of stemness properties and induction of apoptosis in 2D and 3D models of MDA-MB-468. Anticancer Drugs. 2015.
Taghikhani A, Sharifzad F, Mardpour S, Hassan ZMohammad, Ebrahimi M. Tumor extracellular vesicles loaded with exogenous Let-7i and miR-142 can modulate both immune response and tumor microenvironment to initiate a powerful anti-tumor response. Cancer Lett. 2020.